Elanco Animal Health
ELAN
523 hedge funds and large institutions have $13.9B invested in Elanco Animal Health in 2026 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 164 increasing their positions, 211 reducing their positions, and 71 closing their positions.
79% more call options, than puts
Call options by funds: $10.7M | Put options by funds: $5.97M
13% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 71
7% more capital invested
Capital invested by funds: $13B → $13.9B (+$898M)
4.29% more ownership
Funds ownership: 109.73% → 114.02% (+4.3%)
1% more funds holding
Funds holding: 519 → 523 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
22% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 211
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$139M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$122M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$70.5M |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$59M |
| 5 |
FGP
Freestone Grove Partners
San Francisco,
California
|
+$50.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$136M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$82.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$65.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$42.1M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$35.8M |
ELAN Hedge Fund Activity: Q2 2026 in Review
523 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2026, worth a combined $13.9B — up 6.9% from $13B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new ELAN positions and 71 closed out — a net gain of 9 holders — while 164 added to existing stakes and 211 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $139M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $136M.
- 523 institutional investors held Elanco Animal Health (ELAN) as of Q2 2026, up from 519 in Q1 2026.
- Funds reported $13.9B of Elanco Animal Health stock for Q2 2026, up 6.9% quarter-over-quarter.
- 80 funds opened new Elanco Animal Health positions in Q2 2026 and 71 closed out, a net change of +9 holders.
- The largest Elanco Animal Health buyer in Q2 2026 was Fidelity Investments, an estimated $139M added.
- The largest Elanco Animal Health seller in Q2 2026 was T. Rowe Price Investment Management, an estimated $136M sold.
Based on aggregated 13F filings for Q2 2026.